Evidence map›Paper›PMID 42063666›Full record

ArticleInternational journal of cardiology. Heart & vasculature2026

Peak aortic jet velocity as a predictor of short- and long-term outcomes following percutaneous coronary intervention.

Takamasa Iwai, Kensuke Takagi, Takeshi Kitai, Yasuhide Asaumi, Yoko Sumita, Yoshitaka Iwanaga, Michikazu Nakai, Teruo Noguchi, Yoshihiro Miyamoto, Kotaro Nochioka and 18 more

Abstract read
In one paragraph

Article in International journal of cardiology. Heart & vasculature, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Takamasa IwaiDepartment of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan.
Kensuke TakagiDepartment of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan.
Takeshi KitaiDepartment of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan.
Yasuhide AsaumiDepartment of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan.
Yoko SumitaDepartment of Medical and Health Information Management, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Yoshitaka IwanagaDepartment of Medical and Health Information Management, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Michikazu NakaiDepartment of Medical and Health Information Management, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Teruo NoguchiDepartment of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan.
Yoshihiro MiyamotoDepartment of Medical and Health Information Management, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Kotaro NochiokaDivision of Cardiovascular Medicine, Tohoku University Hospital, Sendai, Japan.
Masaharu NakayamaDepartment of Medical Informatics, Tohoku University Graduate School of Medicine, Sendai, Japan.
Naoyuki AkashiDivision of Cardiovascular Medicine, Jichi Medical University Saitama Medical Center, Saitama, Japan.
Tetsuya MatobaDepartment of Cardiovascular Medicine, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
Takahide KohroDepartment of Clinical Informatics, Jichi Medical University School of Medicine, Tochigi, Japan.
Yusuke ObaDivision of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan.
Tomoyuki KabutoyaDivision of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan.
Yasushi ImaiDivision of Clinical Pharmacology, Department of Pharmacology, Jichi Medical University, Tochigi, Japan.
Kazuomi KarioDivision of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan.
Arihiro KiyosueDepartment of Cardiovascular Medicine, University of Tokyo Hospital, Tokyo, Japan.
Yoshiko MizunoDepartment of Cardiovascular Medicine, University of Tokyo Hospital, Tokyo, Japan.
Masanobu IshiiDepartment of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Taishi NakamuraDepartment of Medical Information Science, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Kenichi TsujitaDepartment of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Yuri MatobaPrecision Inc., Tokyo, Japan.
Hisahiko SatoPrecision Inc., Tokyo, Japan.
Hideo FujitaDivision of Cardiovascular Medicine, Jichi Medical University Saitama Medical Center, Saitama, Japan.
Ryozo NagaiJichi Medical University School of Medicine, Tochigi, Japan.
CLIDAS research group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Coronary artery disease (CAD) and aortic valve stenosis (AS) often coexist, with AS exacerbating myocardial ischemia and affecting prognosis. Aims: To investigate the prognostic impact of AS stratified by peak aortic jet velocity (AV-Vel) in patients undergoing PCI. Methods and results: We conducted retrospective multicenter observational study involving patients who underwent percutaneous coronary intervention (PCI) between April 2013 and March 2019. The patients were divided into non-AS group and AS group. The AS group was further categorized: 2.6 ≤ AV-Vel < 3.0 m/s, mild AS; 3.0 ≤ AV-Vel < 4.0 m/s, moderate AS; and AV-Vel ≥ 4.0 m/s, severe AS. The primary outcome was all-cause mortality, and the secondary outcome was major adverse cardiovascular events (MACE), defined as a composite of all-cause mortality, myocardial infarction, or stroke. Multivariable Cox proportional hazards analysis was performed over 5-year observation period, with landmark analyses conducted at 30 days after PCI and from day 31 after PCI to 5 years. In total, 9,690 patients were analyzed (AS group, n = 361). Over a median follow-up of 2.57 (IQR: 0.89-4.24) years, AS group exhibited higher rates of mortality (HR: 3.06; 95% CI: 2.41-3.90; p < 0.001) and MACE (HR: 2.45; 95%CI: 1.97-3.04; p < 0.001) compared with non-AS group. Subgroup analysis revealed that patients with moderate and severe AS had worse short-term mortality and MACE within 30 days after PCI than the non-AS group, while patients with mild to severe AS showed significantly worse long-term outcomes than the non-AS group. Conclusions: AV-Vel is independently associated with both short- and long-term outcomes in patients undergoing PCI.

Indexed as

Aortic stenosisCoronary artery diseasePeak aortic jet velocityPercutaneous coronary intervention

Identifiers

PMID42063666
PMCPMC13127269

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.